Kelun-Biotech announces Breakthrough Therapy Designation granted in China for Sacituzumab Tirumotecan (sac-TMT) in combination with...

Kelun-Biotech receives Investigational New Drug Approval for ITGB6-targeted ADC SKB105 from the NMPA

Whitehawk Therapeutics advances to clinical stage with IND clearance for HWK-007 and announces IND submission...

Lonza’s Synaffix and Sidewinder Therapeutics announce multi-target License agreement to advance development of nextgeneration Bispecific...

InduPro Therapeutics announces strategic collaboration with Lilly to develop first-in-class Bispecific/Multispecific oncology therapeutics using InduPro’s...

Convergent Therapeutics and NorthStar Medical Radioisotopes announce expanded partnership to support Convergent’s late-stage alpha-emitting radioantibody...